Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, is a persistent infectious disease with significant global impact. Amidst the challenges presented by tuberculosis, optimizing infection control and management for acute and critically ill patients remains imperative. This study addresses this need by investigating the efficacy of standardized risk management in enhancing care outcomes.
Objective: The study aims to investigate the impact of standardized risk management on infection control and the management of acute and critically ill patients in a tuberculosis clinic.
Design: A randomized controlled experiment was employed for this study.
Setting: The research took place at Qingdao Haici Medical Group.
Participants: A total of 96 patients with acute and severe tuberculosis treated in the outpatient department from January 2020 to December 2022 were randomly assigned to the control group (CG) and the observation group (OG), with 48 cases in each group.
Interventions: Patients in the CG received conventional management, while those in the OG underwent standardized risk management.
Primary outcome measures: (1) incidence of infection events; (2) quality of management; (3) outpatient health indicators; and (4) patient satisfaction.
Results: The OG exhibited a lower incidence of infection events compared to the CG (P < .05). Quality management scores were higher in the OG (P < .05). The OG demonstrated a higher qualified rate in air quality, disinfectant standards, hand hygiene, and mechanical use compared to the CG (P < .05). Patient satisfaction was higher in the OG (χ2=7.21, P < .05).
Conclusions: The application of standardized risk management in infection control and management of acute and critically ill patients in tuberculosis clinics significantly reduced the incidence of infection events and improved patient satisfaction with nursing. This approach is considered worthy of widespread implementation.